News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial
Jan 6, 2025, 11:11

Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:

“Switching 5 FU for docetaxel in the Tp-EXTREME trial results in similar OS with a better safety profile.”

Akhil Santhosh

Akhil Santhosh cancer docetaxel MVR Cancer Centre OncoDaily Oncology Tp-EXTREME trial
Special Coverage
Blog
Feb 13, 2025, 09:10
Yüksel Ürün: Excited to see the GU25 ASCO Featured Voices lineup
Societies
Feb 13, 2025, 09:06
Nominations Open for Secretary General for SIOP Africa - SIOP International
Blog
Feb 13, 2025, 08:58
Colorectal Cancer is increasing in its incidence in Nigeria - Project PINK BLUE
Science
Feb 13, 2025, 08:53
Rami Manochakian: Osimertinib and Cardiotoxicity - a topic to keep addressing
Science
Feb 13, 2025, 08:52
Gustavo Viani: SBRT vs. ablation for kidney cancer - a game-changer?
Blog
Feb 13, 2025, 08:16
Wafaa Rashed: Recent funding cuts threaten the future of lifesaving treatments
Insight
Feb 13, 2025, 08:15
Our first hypofractionated glioblastoma multiforme treatment - UTSW Radiation Oncology
Blog
Feb 13, 2025, 08:03
Interactive training modules on integrative medicine for anxiety, depression, pain - SIO
Science
Feb 13, 2025, 07:54
Ravi Madan: The true value of PFS endpoints in prostate cancer
Science
Feb 13, 2025, 07:52
Nina Niu Sanford: Phase I trial of pre-op SBRT for resectable pancreas cancer
Blog
Feb 13, 2025, 07:47
Emre Yekedüz: My Top 10 selection for GU25 ASCO!
Science
Feb 13, 2025, 07:41
Yüksel Ürün: SBRT, A powerful option for inoperable RCC